It will compete with Eisai and Biogen's Leqembi, which the FDA approved last year ... Go deeper: Where the future of Alzheimer's drugs is heading Get more health news in your inbox with Axios ...

Fosgonimeton, aimed at protecting neurons, failed to do better than placebo at slowing cognitive decline in patients with ...

A chemist a UAlbany and his son are looking to make a major breakthrough in the world of Alzheimer's prevention. They believe ...

New research reveals a potential breakthrough in Alzheimer’s treatment, showing that the drug troriluzole can reverse memory ...

A recent study found people taking a particular type of diabetes drug had a lower risk of developing dementia.

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University report that they were able to successfully put tadpoles of Xenopus laevis frogs into a hibernation-like ...

NASHVILLE, Tenn. (WSMV) - KCA Neurology in Middle Tennessee has recently launched a National Institutes of Health-funded ...

In a recent development in Alzheimer's disease research, Auburn University scientists have studied a new drug, troriluzole, ...

U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected ...

Nvidia-backed Recursion Pharmaceuticals said on Tuesday its experimental drug to treat a rare brain-related condition was ...

Eli Lilly received FDA breakthrough status for its donanemab Alzheimer's drug, speeding the agency's review of the product. The shares are higher. Eli Lilly (LLY) shares rose Thursday after ...